6 drugs in portfolio
Dna Labs Inc is a pharmaceutical manufacturer with 6 drugs tracked in the FDA Adverse Event Reporting System (FAERS) database. This page provides a comprehensive safety overview of all drugs manufactured by Dna Labs Inc, including individual drug safety scores and links to detailed adverse event analyses.
The safety data presented here is derived from FDA adverse event reports submitted by healthcare professionals, patients, and manufacturers. These reports are voluntarily submitted and do not by themselves prove that a drug caused an adverse event. However, patterns in reporting volume and severity across a manufacturer's portfolio can provide useful context when evaluating medication safety.
Below is the full list of drugs manufactured by Dna Labs Inc that appear in the FDA adverse event database, along with their individual safety scores. Click on any drug name to view its complete side effect profile, adverse reaction breakdown, and AI-powered safety analysis.
The average safety score for Dna Labs Inc is computed by aggregating the individual safety scores of each drug in their portfolio. Each drug's safety score is based on the total number of FDA adverse event reports, the severity of reported outcomes including hospitalizations and deaths, and the proportion of serious versus non-serious events. A higher score indicates fewer and less severe adverse events relative to the drug's usage volume.